Comparison
Omega-3 (DHA/EPA) vs Urolithin A (Mitopure)
Omega-3 (DHA/EPA)
Essential fatty acids critical for brain structure and function. DHA comprises ~40% of brain polyunsaturated fatty acids.
Urolithin A (Mitopure)
Bioactive metabolite of pomegranate ellagitannins. Direct mitophagy activator. The supplement form bypasses the gut microbiome variability.
| Field | Omega-3 (DHA/EPA) | Urolithin A (Mitopure) |
|---|---|---|
| Category | neuroprotective | neuroprotective |
| Dose range | 1000–3000mg | 500–1000mg |
| Half-life | 24h | — |
| Onset | — | — |
| Evidence | EVIDENCEA | EVIDENCEB |
| Safety | ●●●●● | ●●●●● |
| Legal (US) | USOTC | USOTC |
| PubMed refs | 5200 | 280 |
The comparison in plain English
Auto-generated from dataOmega-3 (DHA/EPA) and Urolithin A (Mitopure) are both in the neuroprotective category respectively. Omega-3 (DHA/EPA) Essential fatty acids critical for brain structure and function. Urolithin A (Mitopure) Bioactive metabolite of pomegranate ellagitannins.
Bottom line
Omega-3 (DHA/EPA) (evidence A, safety 5/5) has a weaker evidence base than Urolithin A (Mitopure) (evidence B, safety 5/5). Omega-3 (DHA/EPA) has the slightly cleaner safety profile. For users new to either, the higher-evidence option is the safer first try.
Choose Omega-3 (DHA/EPA) if
Omega-3 (DHA/EPA) is the better fit when your goal aligns with its mechanism (DHA (docosahexaenoic acid) is a structural component of neuronal cell membranes, maintaining fluidity and supporting receptor function) and the dose range (1000–3000mg) suits your protocol. Half-life is 24h.
Choose Urolithin A (Mitopure) if
Urolithin A (Mitopure) is the better fit when your goal aligns with its mechanism (Selectively activates mitophagy — the autophagy of damaged mitochondria — through PINK1/Parkin signaling) and the dose range (500–1000mg) suits your protocol. Half-life is —h.